Currently out of the existing stock ratings of Casey Woodring, 12 are a HOLD (44.44%), 5 are a SELL (18.52%), 10 are a BUY (37.04%).

Casey Woodring

Work Performance Price Targets & Ratings Chart

Analyst Casey Woodring, currently employed at JPMORGAN, carries an average stock price target met ratio of 49.05% that have a potential upside of 11.01% achieved within 44 days.

Casey Woodring’s has documented 54 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on CRL, Charles River Laboratories at 15-Dec-2025.

Wall Street Analyst Casey Woodring

Analyst best performing recommendations are on QDEL (QUIDEL).
The best stock recommendation documented was for QDEL (QUIDEL) at 4/21/2025. The price target of $25 was fulfilled within 2 days with a profit of $0.44 (1.79%) receiving and performance score of 8.96.

Average potential price target upside

QDEL Quidel SHC Sotera Health Co SYNH Syneos Health CRL Charles River Laboratories HOLX Hologic ICLR ICON PLC

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell

Since 14-Feb-2024

$22

$-11.65 (-34.62%)

$25

2 months 3 days ago
(07-Nov-2025)

4/6 (66.67%)

$0.74 (3.48%)

34

Buy

Since 08-May-2025

$44

$10.35 (30.76%)

$43

8 months 2 days ago
(08-May-2025)

7/8 (87.5%)

$7.54 (20.68%)

196

Hold

Since 19-Sep-2024

$45

$11.35 (33.73%)

$50

10 months 28 days ago
(13-Feb-2025)

1/3 (33.33%)

$3.35 (8.04%)

42

Buy

Since 07-May-2020

$57

$23.35 (69.39%)

$50

1 years 4 months 5 days ago
(05-Sep-2024)

5/13 (38.46%)

$12.5 (28.09%)

154

Buy

Since 22-Jan-2021

$76

$42.35 (125.85%)

$100

1 years 10 months 27 days ago
(14-Feb-2024)

2/9 (22.22%)

$30.73 (67.88%)

16

Show more analysts

Please expand the browser size to see the chart

Which stock is Casey Woodring is most bullish on?

Potential upside of $3.13 has been obtained for HOLX (HOLOGIC)

Which stock is Casey Woodring is most reserved on?

Potential downside of -$30.91 has been obtained for CRL (CHARLES RIVER LABORATORIES)

What Year was the first public recommendation made by Casey Woodring?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?